Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system

Balázs Sarkadi1, László Homolya, Gergely Szakács

  • 1National Medical Center, Institute of Hematology and Immunology, Membrane Research Group, Budapest, Hungary. sarkadi@biomembrane.hu

Physiological Reviews
|October 4, 2006
PubMed

Insights

Multidrug resistance (MDR) ATP binding cassette (ABC) transporters protect against foreign compounds. These conserved proteins form a "chemoimmunity" network, crucial for innate defense in all living systems.

Area of Science:

  • Biochemistry and Cell Biology
  • Physiology
  • Molecular Biology

Background:

  • ATP binding cassette (ABC) transporters, initially identified as multidrug resistance (MDR) proteins, possess critical physiological roles.
  • These transporters are vital for protecting organisms against hydrophobic xenobiotics.
  • Their conserved structure and function across species highlight their fundamental importance.

Purpose of the Study:

  • To review the physiological functions of MDR-ABC transporters.
  • To detail the structure, mechanism, and analysis methods for human MDR-ABC transporters.
  • To explore the roles of specific transporters like ABCB1 and ABCG2 in drug and xenobiotic resistance.

Main Methods:

  • Review of existing literature on MDR-ABC transporter physiology.
  • Analysis of structural and mechanistic features of human MDR-ABC transporters.
  • Biochemical, cell biology, and physiological examination of ABCB1 and ABCG2.

Main Results:

  • MDR-ABC transporters play a key role in cancer drug resistance and xenobiotic protection.
  • These transporters exhibit conserved structural and mechanistic properties across all life forms.
  • ABCB1 and ABCG2 are significant MDR-ABC transporters with emerging roles for other ABCB and ABCG types.

Conclusions:

  • MDR-ABC transporters function as a network at cellular and tissue barriers, forming an innate "chemoimmunity" defense system.
  • These transporters are essential for protecting against a wide range of hydrophobic xenobiotics.
  • Understanding MDR-ABC transporters provides insights into innate defense mechanisms and potential therapeutic strategies.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...